DI PUNZIO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 360
EU - Europa 298
AS - Asia 145
AF - Africa 4
OC - Oceania 1
Totale 808
Nazione #
US - Stati Uniti d'America 359
IT - Italia 94
IE - Irlanda 79
CN - Cina 76
SE - Svezia 65
SG - Singapore 61
DE - Germania 16
GB - Regno Unito 14
FR - Francia 12
BE - Belgio 11
FI - Finlandia 4
CI - Costa d'Avorio 3
IN - India 3
RU - Federazione Russa 3
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
IR - Iran 1
JP - Giappone 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 808
Città #
Chandler 84
Dublin 68
Ann Arbor 64
Singapore 51
Shanghai 22
Ashburn 19
Boardman 19
Santa Clara 15
Beijing 13
Princeton 12
Brussels 11
Dearborn 11
Parma 9
Colchester 8
Los Angeles 8
Gravina di Catania 7
Wilmington 7
Fontanellato 6
New York 6
Woodbridge 6
Des Moines 5
Nanjing 5
Avola 4
Bologna 4
Falls Church 4
Ferrara 4
Guangzhou 4
Helsinki 4
Jinan 4
Marseille 4
Messina 4
Milan 4
Piacenza 4
Reggio Nell'emilia 4
Rome 4
Scafati 4
Trezzano Sul Naviglio 4
Zhengzhou 4
Abidjan 3
Bremen 3
Brescia 3
Houston 3
Pune 3
Carpi 2
Dosolo 2
Fremont 2
Kunming 2
Nanchang 2
Palermo 2
Pistoia 2
Redmond 2
Saint-Fons 2
Slough 2
St Petersburg 2
Taiyuan 2
Baku 1
Berlin 1
Cambridge 1
Cape Town 1
Dallas 1
Danyang 1
Elyria 1
Frankfurt am Main 1
Fuzhou 1
Garching 1
Gatchina 1
Gloucester 1
Hangzhou 1
Istanbul 1
La Jolla 1
Langhirano 1
Leawood 1
Lecce 1
Lidköping 1
Manchester 1
Melbourne 1
Modena 1
Munich 1
Ningbo 1
Novara 1
Padova 1
Peterborough 1
Philadelphia 1
Rockville 1
Sabz 1
San Gregorio di Catania 1
Seattle 1
Stockholm 1
Tappahannock 1
Tokyo 1
Toronto 1
Vezzano sul Crostolo 1
Washington 1
Xian 1
Zibo 1
Totale 599
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 93
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 79
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 77
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 76
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 72
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 70
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 67
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 64
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 58
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 55
The power of yeast in modeling human mutations leading to mitochondrial disease 51
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 50
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 22
Totale 834
Categoria #
all - tutte 3.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 2 8 11 3 3 6 6 2
2020/202183 2 1 16 2 5 4 4 3 9 22 7 8
2021/2022110 9 3 0 16 6 20 4 8 2 4 5 33
2022/2023303 30 34 34 19 18 31 9 15 89 2 15 7
2023/2024140 15 13 6 12 9 20 10 9 4 12 11 19
2024/2025126 9 14 27 27 49 0 0 0 0 0 0 0
Totale 834